The surgical heart valve market includes two sub-markets, the tissue heart valve, and the mechanical heart valve markets. The global tissue heart valve market size is estimated to increase over the forecast period to exceed $1.2 billion by 2027. The global mechanical heart valve market size is projected to reach $153.6 million by 2027. Lastly, the global annuloplasty repair device market is expected to increase over the forecast period to reach $246.9 million by 2027.
Edwards Lifesciences, Medtronic, and Abbott were the share leaders in the global tissue heart valve market. This global analysis covers over 70 countries, includes in-depth procedure numbers by country, and is segmented into the stented tissue heart valve market, the sutureless/rapid deployment tissue heart valve market, and the stentless tissue heart valve market. A driver of growth in the tissue heart valve market is the advent of advanced technologies such as sutureless/rapid deployment valves.
Abbott, Cryolife, and Sorin were the share leaders in the global mechanical heart valve market. This global analysis covers over 70 countries, and in-depth procedure numbers by country including the aortic, mitral, pulmonary, and tricuspid mechanical heart valve procedures. The main benefit of mechanical heart valves over tissue valves is their high durability, often lasting beyond the lifetime of the patient.
Edwards Lifesciences, Medtronic, and LivaNova were the share leaders in the global annuloplasty repair device market. This global analysis covers over 70 countries, and in-depth procedure numbers by country including the mitral, and tricuspid mechanical annuloplasty repair procedures. Annuloplasty repair procedures are most common in the population of patients over age 65. As the global population ages, the market is set to grow over the forecast period.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2027, and Historical Data to 2017
- Recent Mergers & Acquisitions
- Disease Overviews
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
Procedure numbers for the surgical heart valve market include mechanical heart valves, tissue heart valves, and annuloplasty repair. For all three, the procedure numbers are divided by country with an in-depth analysis including information ranging from 2017 to 2027. The mechanical heart valve procedure numbers are further broken down per procedure including the aortic, mitral, pulmonary, and tricuspid procedures. The annuloplasty repair procedure numbers are further broken down per procedure including the mitral, and tricuspid procedures.
Tissue Heart Valve Market Insights
Growth within this market is primarily driven by unit sales which are powered by the continued shift in preference for tissue heart valves over the mechanical options. Overall, the market will experience slight growth over the forecast period as sutureless heart valve procedures and advancements increase and the elderly population expands. Tissue heart valves have an advantage over mechanical heart valves as they do not require the patient to take anti-coagulants, evidently making it the more popular option.
Mechanical Heart Valve Market Insights
The mechanical heart valve market was led by aortic procedures in 2020. Growth, however, will not occur as this market is currently decreasing over the forecast period. These heart valves were rarely used to replace the tricuspid or pulmonary valves, and as a result, unit sales are decreasing. The largest limiter within this market is the need for anticoagulant therapy for the remainder of the patient’s life after the procedure. Despite this, advancements in technology surrounding the development of biocompatible polymers to reduce the formation of blood clots are underway. Patients would no longer need to use anti-coagulants and because of this, the market could experience growth.
Annuloplasty Repair Device Market Insights
Annuloplasty repair procedures are the most common among patients over the age of 65. Therefore, growth within this market will increase as the proportion of the global population over the age of 65 increases. As a result of this, unit sales will increase along with the increasing population age and will allow the market to consequently increase at a modest rate. Along with this, advancements in minimally invasive repair procedures are being made which will improve patient outcomes and help fuel the growth of the repair market. In terms of limiters, the popular transcatheter heart valve repair procedure is rapidly growing and taking demand away from annuloplasty procedures.
MARKET SHARE INSIGHTS
The global surgical heart valve market is controlled by Edwards Lifesciences, Medtronic, Abbott, Cryolife, Sorin, and LivaNova. In 2020, Edwards Lifesciences was the leader in the tissue heart valve market, capturing over 50% of the global market share. This company was also the leader in the annuloplasty repair device market. In 2020, Abbott was the leading competitor in the mechanical heart valve market. In the past, St. Jude Medical had previously controlled a larger share of the market; however, as Abbott has focused on other valve types, other companies have obtained some of its shares.
RESEARCH REGIONAL COVERAGE
Throughout this report, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:
- North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)